Guidance for Industry and FDA Staff: IND Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System
Source: What's New at CBER - Category: Biomedical Science Source Type: news
More News: Allergy & Immunology | Biomedical Science